Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The aim of the study was to evaluate the effect of pantoprazole on sleep disorders in
patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux
disease). The prevalence and intensity of the sleep disorders were evaluated by a
standardized questionnaire. The study was expected to provide further data on safety and
tolerability of pantoprazole.